ULW-22095-04683
2 vaccinations
2 coded responses
9 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 287 / NC
- Registered
- 2021-08-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-27
Registered in v-safe
-
2021-08-27
Dose 1 — Pfizer-BioNTech
-
2021-08-27
Survey response — day 0, dose 1MedDRA: Pregnancy — Feeling: Fair · Fatigue or tirednessFree text: 23 weeks pregnantMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-09-01
- 2021-09-12
-
2021-09-18
Dose 2 — Pfizer-BioNTech
-
2021-09-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-09-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains, Nausea, Vomiting · Be unable to work or attend schoolAdult check-in
- 2021-09-22
-
2021-09-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-20
Survey response — 3 months, dose 2MedDRA: Adverse reaction, Caesarean section, Hospitalisation, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Developed pre-eclampsia with severe features 3 days after my second shot I was in the hospital for two weeks before having an emergency c-section at 27 weeks. · Healthcare visit (other): Described aboveMedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
-
2021-12-22
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-27 | Pfizer-BioNTech | No |
| 2 | 2021-09-18 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 9 — day 0, dose 1
Systemic reaction (other): 23 weeks pregnant
Release 10 — 3 months, dose 2
Symptoms: Developed pre-eclampsia with severe features 3 days after my second shot I was in the hospital for two weeks before having an emergency c-section at 27 weeks.
Healthcare visit (other): Described above
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Adverse reaction | · | · | ✓ |
| SD | Caesarean section | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SRO | Pregnancy | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release